Skip to main content

Company News

October 23, 2024

Global Response to the 2024 Mpox Outbreak: Need for Enhanced Diagnostics and Equitable Resource Distribution

Fast, effective diagnostics are crucial in the identification of individuals infected with monkeypox (MPXV); a potentially fatal virus previously known as monkeypox. The outbreak was declared a public health emergency of international concern by the World Health Organization (WHO) in August 2024, just two years after a similar occurrence in 2022. Many top health officials have called for a coordinated international response to curb the spread and save lives. Drawing on this experience, University of Alabama at Birmingham Professor and epidemiologist David O. Freedman, contributes insights into managing outbreaks in a post-pandemic world.
Discover More

  • June 10, 2024

    USDA Awards bioMérieux GENE-UP® CAMPYLOBACTER as Method of Choice for Campylobacter Detection in USDA Food Safety and Inspection Service Laboratories

    GENE-UP® CAMPYLOBACTER is a real-time PCR-based solution that delivers results in under an hour and is AOAC validated for a variety of enrichment medias.

    Read more

  • June 04, 2024

    A new R&D building in Italy to innovate in combatting Antimicrobial Resistance

    bioMérieux inaugurated its new Rodolphe Mérieux Campus on May 31, in Bagno a Ripoli, Italy, in the presence of Alain Mérieux, Chairman of Institut Mérieux, and Pierre Boulud, Chief Executive Officer of bioMérieux. The site comprises of a new R&D center focusing on the fight against Antimicrobial Resistance. This is the result of an investment of €9 million.
    Read more

  • April 15, 2024

    bioMérieux Named Business of the Year by Utah Governor’s Office of Economic Opportunity

    bioMérieux, a world leader in the field of in vitro diagnostics, has received the 2024 Business of the Year Award, presented by the Utah Governor’s Office of Economic Opportunity at One Utah Summit April 11-12, in Salt Lake City.
    Read more

  • March 19, 2024

    bioMérieux and the Food and Drug Administration Launch Research Collaboration to Improve Microbial Detection Tools to Combat Food-Borne Pathogens

    bioMérieux has entered into a strategic research collaboration with the US Food and Drug Administration (FDA), Center for Food Safety and Applied Nutrition (CFSAN), Offices of Applied Research and Safety Assessment (OARSA) and Regulatory Science (ORS) to develop tools to combat food-borne pathogens.
    Read more

Follow us on Socials for more news!